Pulse Biosciences Inc (PLSE) Stock Analysis

Pulse Biosciences Inc (PLSE) is a publicly traded company in the HEALTHCARE sector. It trades at $24.28, carries a market capitalization of $1.71B. This page summarizes the public market data, fundamentals, and frequently asked questions for PLSE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Pulse Biosciences Inc currently has a Bullish sentiment score of 0.31.

About Pulse Biosciences Inc

Pulse Biosciences, Inc. is a pioneering bioelectrical medicine company headquartered in Hayward, California, dedicated to advancing therapeutic options through its proprietary Nano-Pulse Stimulation (NPS) technology. This innovative platform aims to provide non-invasive treatments that effectively disrupt cellular processes to promote healing across various medical fields, including dermatology and oncology. By addressing significant unmet medical needs, Pulse Biosciences is well-positioned f...

GNG Research Analysis

GNG Research scores Pulse Biosciences Inc (PLSE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PLSE.

Frequently Asked Questions

Does PLSE pay dividends?

Pulse Biosciences Inc (PLSE) does not currently pay a regular dividend.

What is PLSE's market cap?

Pulse Biosciences Inc (PLSE) has a market capitalization of $1.71B with a current stock price of $24.28.